{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:13:12Z","timestamp":1793211192884,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jilin Provincial Science and Technology Commission International Science and Technology Cooperation","award":["20230402015GH"],"award-info":[{"award-number":["20230402015GH"]}]},{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"crossref","award":["2021SCZ24"],"award-info":[{"award-number":["2021SCZ24"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jilin Provincial Science and Technology Development Plan Project","award":["20210101258JC"],"award-info":[{"award-number":["20210101258JC"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s11010-023-04812-1","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T04:02:33Z","timestamp":1692244953000},"page":"1571-1582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mitochondria and NLRP3 inflammasome in cardiac hypertrophy"],"prefix":"10.1007","volume":"479","author":[{"given":"Ruyu","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"issue":"6","key":"4812_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","volume":"121","author":"P Joseph","year":"2017","unstructured":"Joseph P et al (2017) Reducing the global burden of cardiovascular disease, Part 1: the epidemiology and risk factors. Circ Res 121(6):677\u2013694","journal-title":"Circ Res"},{"issue":"10159","key":"4812_CR2","first-page":"1736","volume":"392","author":"AR Gregory","year":"2017","unstructured":"Gregory AR et al (2017) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study. Lancet 392(10159):1736\u20131788","journal-title":"Lancet"},{"issue":"6","key":"4812_CR3","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1002\/ehf2.13065","volume":"7","author":"W Yu","year":"2020","unstructured":"Yu W, Chen C, Cheng J (2020) The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy. ESC Heart Fail 7(6):3497\u20133504","journal-title":"ESC Heart Fail"},{"issue":"3","key":"4812_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/eurheartj\/ehaa914","volume":"42","author":"M Mele","year":"2021","unstructured":"Mele M et al (2021) Diagnosis of acute myocardial infarction in the time of the COVID-19 pandemic. Eur Heart J 42(3):286","journal-title":"Eur Heart J"},{"issue":"6","key":"4812_CR5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/antiox10060931","volume":"10","author":"AK Shah","year":"2021","unstructured":"Shah AK et al (2021) Oxidative stress as a mechanism for functional alterations in cardiac hypertrophy and heart failure. Antioxidants (Basel) 10(6):931","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"4812_CR6","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.112.112185","volume":"126","author":"SK Verma","year":"2012","unstructured":"Verma SK et al (2012) Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-\u03baB. Circulation 126(4):418\u2013429","journal-title":"Circulation"},{"issue":"11","key":"4812_CR7","first-page":"828","volume":"38","author":"GP van Hout","year":"2017","unstructured":"van Hout GP et al (2017) The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction. Eur Heart J 38(11):828\u2013836","journal-title":"Eur Heart J"},{"key":"4812_CR8","first-page":"9","volume":"108","author":"GPJ van Hout","year":"2018","unstructured":"van Hout GPJ, Bosch L (2018) The inflammasomes in cardiovascular disease. Exp Suppl 108:9\u201340","journal-title":"Exp Suppl"},{"issue":"19","key":"4812_CR9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1101\/gad.269894.115","volume":"29","author":"GW Dorn 2nd","year":"2015","unstructured":"Dorn GW 2nd, Vega RB, Kelly DP (2015) Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev 29(19):1981\u20131991","journal-title":"Genes Dev"},{"issue":"2","key":"4812_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","volume":"98","author":"CJ Oldfield","year":"2020","unstructured":"Oldfield CJ, Duhamel TA, Dhalla NS (2020) Mechanisms for the transition from physiological to pathological cardiac hypertrophy. Can J Physiol Pharmacol 98(2):74\u201384","journal-title":"Can J Physiol Pharmacol"},{"issue":"10","key":"4812_CR11","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.3390\/ijms22105277","volume":"22","author":"M Fioranelli","year":"2021","unstructured":"Fioranelli M et al (2021) Regulation of inflammatory reaction in health and disease. Int J Mol Sci 22(10):5277","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4812_CR12","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.4049\/jimmunol.1301539","volume":"191","author":"H Shen","year":"2013","unstructured":"Shen H, Kreisel D, Goldstein DR (2013) Processes of sterile inflammation. J Immunol 191(6):2857\u20132863","journal-title":"J Immunol"},{"issue":"1","key":"4812_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12296","volume":"265","author":"SM Man","year":"2015","unstructured":"Man SM, Kanneganti TD (2015) Regulation of inflammasome activation. Immunol Rev 265(1):6\u201321","journal-title":"Immunol Rev"},{"issue":"2","key":"4812_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molmed.2016.12.007","volume":"23","author":"MN Patel","year":"2017","unstructured":"Patel MN et al (2017) Inflammasome priming in sterile inflammatory disease. Trends Mol Med 23(2):165\u2013180","journal-title":"Trends Mol Med"},{"issue":"2","key":"4812_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind FG et al (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183(2):787\u2013791","journal-title":"J Immunol"},{"issue":"8","key":"4812_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19(8):477\u2013489","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4812_CR17","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","volume":"38","author":"R Mu\u00f1oz-Planillo","year":"2013","unstructured":"Mu\u00f1oz-Planillo R et al (2013) K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38(6):1142\u20131153","journal-title":"Immunity"},{"issue":"28","key":"4812_CR18","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.1117765109","volume":"109","author":"T Murakami","year":"2012","unstructured":"Murakami T et al (2012) Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A 109(28):11282\u201311287","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"4812_CR19","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.4049\/jimmunol.175.11.7623","volume":"175","author":"PA Verhoef","year":"2005","unstructured":"Verhoef PA et al (2005) Inhibitory effects of chloride on the activation of caspase-1, IL-1beta secretion, and cytolysis by the P2X7 receptor. J Immunol 175(11):7623\u20137634","journal-title":"J Immunol"},{"key":"4812_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.tiv.2017.10.017","volume":"46","author":"Z Liu","year":"2018","unstructured":"Liu Z et al (2018) Silymarin attenuated paraquat-induced cytotoxicity in macrophage by regulating Trx\/TXNIP complex, inhibiting NLRP3 inflammasome activation and apoptosis. Toxicol In Vitro 46:265\u2013272","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"4812_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","volume":"36","author":"K Shimada","year":"2012","unstructured":"Shimada K et al (2012) Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36(3):401\u2013414","journal-title":"Immunity"},{"issue":"2","key":"4812_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","volume":"39","author":"SS Iyer","year":"2013","unstructured":"Iyer SS et al (2013) Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39(2):311\u2013323","journal-title":"Immunity"},{"issue":"8","key":"4812_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung V et al (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9(8):847\u2013856","journal-title":"Nat Immunol"},{"issue":"12","key":"4812_CR24","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","volume":"122","author":"A Grebe","year":"2018","unstructured":"Grebe A, Hoss F, Latz E (2018) NLRP3 inflammasome and the IL-1 pathway in atherosclerosis. Circ Res 122(12):1722\u20131740","journal-title":"Circ Res"},{"key":"4812_CR25","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.248344","author":"ANR Weber","year":"2020","unstructured":"Weber ANR et al (2020) Recent insights into the regulatory networks of NLRP3 inflammasome activation. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.248344","journal-title":"J Cell Sci"},{"issue":"1","key":"4812_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/imr.12286","volume":"265","author":"EI Elliott","year":"2015","unstructured":"Elliott EI, Sutterwala FS (2015) Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev 265(1):35\u201352","journal-title":"Immunol Rev"},{"issue":"4","key":"4812_CR27","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ijcard.2012.09.082","volume":"167","author":"LY Zhou","year":"2013","unstructured":"Zhou LY et al (2013) Mitochondrial function in cardiac hypertrophy. Int J Cardiol 167(4):1118\u20131125","journal-title":"Int J Cardiol"},{"issue":"5923","key":"4812_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann O et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324(5923):98\u2013102","journal-title":"Science"},{"key":"4812_CR29","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a037150","author":"TR Heallen","year":"2020","unstructured":"Heallen TR et al (2020) Determinants of cardiac growth and size. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a037150","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"12","key":"4812_CR30","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/CIRCULATIONAHA.119.042336","volume":"141","author":"X Tang","year":"2020","unstructured":"Tang X et al (2020) SNO-MLP (S-Nitrosylation of Muscle LIM Protein) facilitates myocardial hypertrophy through TLR3 (Toll-Like Receptor 3)-mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) inflammasome activation. Circulation 141(12):984\u20131000","journal-title":"Circulation"},{"issue":"9","key":"4812_CR31","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.7150\/ijbs.26215","volume":"14","author":"Y Dong","year":"2018","unstructured":"Dong Y et al (2018) Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy. Int J Biol Sci 14(9):1133\u20131141","journal-title":"Int J Biol Sci"},{"key":"4812_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.559220","volume":"11","author":"N Stafford","year":"2020","unstructured":"Stafford N et al (2020) Signaling via the Interleukin-10 receptor attenuates cardiac hypertrophy in mice during pressure overload, but not isoproterenol infusion. Front Pharmacol 11:559220","journal-title":"Front Pharmacol"},{"issue":"22","key":"4812_CR33","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1161\/CIRCULATIONAHA.118.034621","volume":"138","author":"T Suetomi","year":"2018","unstructured":"Suetomi T et al (2018) Inflammation and NLRP3 inflammasome activation initiated in response to pressure overload by Ca(2+)\/Calmodulin-dependent protein kinase II \u03b4 signaling in cardiomyocytes are essential for adverse cardiac remodeling. Circulation 138(22):2530\u20132544","journal-title":"Circulation"},{"issue":"11","key":"4812_CR34","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00109-018-1691-0","volume":"96","author":"F Li","year":"2018","unstructured":"Li F et al (2018) NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression. J Mol Med (Berl) 96(11):1189\u20131202","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"4812_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/ijms20020360","volume":"20","author":"XC Pan","year":"2019","unstructured":"Pan XC et al (2019) Dual role of triptolide in interrupting the NLRP3 inflammasome pathway to attenuate cardiac fibrosis. Int J Mol Sci 20(2):360","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4812_CR36","first-page":"5332","volume":"12","author":"T Zhang","year":"2020","unstructured":"Zhang T et al (2020) Astragaloside IV prevents myocardial hypertrophy induced by mechanical stress by activating autophagy and reducing inflammation. Am J Transl Res 12(9):5332\u20135342","journal-title":"Am J Transl Res"},{"issue":"4","key":"4812_CR37","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","volume":"81","author":"T Kubota","year":"1997","unstructured":"Kubota T et al (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81(4):627\u2013635","journal-title":"Circ Res"},{"issue":"2","key":"4812_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","volume":"56","author":"GC Mel\u00e9ndez","year":"2010","unstructured":"Mel\u00e9ndez GC et al (2010) Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 56(2):225\u2013231","journal-title":"Hypertension"},{"issue":"6","key":"4812_CR39","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1172\/JCI117956","volume":"95","author":"JN Palmer","year":"1995","unstructured":"Palmer JN et al (1995) Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest 95(6):2555\u20132564","journal-title":"J Clin Invest"},{"issue":"11","key":"4812_CR40","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","volume":"115","author":"M Sun","year":"2007","unstructured":"Sun M et al (2007) Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115(11):1398\u20131407","journal-title":"Circulation"},{"issue":"5","key":"4812_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035144","volume":"7","author":"F Ma","year":"2012","unstructured":"Ma F et al (2012) Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF \u03b2\/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS ONE 7(5):e35144","journal-title":"PLoS ONE"},{"issue":"11","key":"4812_CR42","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1161\/CIRCRESAHA.109.208199","volume":"105","author":"S Honsho","year":"2009","unstructured":"Honsho S et al (2009) Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Circ Res 105(11):1149\u20131158","journal-title":"Circ Res"},{"issue":"1","key":"4812_CR43","doi-asserted-by":"publisher","first-page":"H76","DOI":"10.1152\/ajpheart.01285.2008","volume":"297","author":"Q Yu","year":"2009","unstructured":"Yu Q et al (2009) IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice. Am J Physiol Heart Circ Physiol 297(1):H76-85","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"4812_CR44","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","volume":"118","author":"AR Pinto","year":"2016","unstructured":"Pinto AR et al (2016) Revisiting cardiac cellular composition. Circ Res 118(3):400\u2013409","journal-title":"Circ Res"},{"issue":"5","key":"4812_CR45","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1080\/15548627.2020.1749490","volume":"17","author":"Y Hu","year":"2021","unstructured":"Hu Y et al (2021) The AMPK-MFN2 axis regulates MAM dynamics and autophagy induced by energy stresses. Autophagy 17(5):1142\u20131156","journal-title":"Autophagy"},{"key":"4812_CR46","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011072","author":"AM van der Bliek","year":"2013","unstructured":"van der Bliek AM, Shen Q, Kawajiri S (2013) Mechanisms of mitochondrial fission and fusion. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a011072","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"4812_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/07853890.2017.1417631","volume":"50","author":"DA Chistiakov","year":"2018","unstructured":"Chistiakov DA et al (2018) The role of mitochondrial dysfunction in cardiovascular disease: a brief review. Ann Med 50(2):121\u2013127","journal-title":"Ann Med"},{"issue":"3","key":"4812_CR48","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","volume":"85","author":"WC Stanley","year":"2005","unstructured":"Stanley WC, Recchia FA, Lopaschuk GD (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85(3):1093\u20131129","journal-title":"Physiol Rev"},{"issue":"12","key":"4812_CR49","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21037\/atm.2018.06.21","volume":"6","author":"G Siasos","year":"2018","unstructured":"Siasos G et al (2018) Mitochondria and cardiovascular diseases-from pathophysiology to treatment. Ann Transl Med 6(12):256","journal-title":"Ann Transl Med"},{"issue":"21","key":"4812_CR50","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1016\/j.jmb.2018.07.027","volume":"430","author":"SB Yu","year":"2018","unstructured":"Yu SB, Pekkurnaz G (2018) Mechanisms orchestrating mitochondrial dynamics for energy homeostasis. J Mol Biol 430(21):3922\u20133941","journal-title":"J Mol Biol"},{"issue":"5","key":"4812_CR51","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41401-020-00518-y","volume":"42","author":"JY Jin","year":"2021","unstructured":"Jin JY et al (2021) Drp1-dependent mitochondrial fission in cardiovascular disease. Acta Pharmacol Sin 42(5):655\u2013664","journal-title":"Acta Pharmacol Sin"},{"issue":"23","key":"4812_CR52","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.lfs.2007.04.003","volume":"80","author":"L Fang","year":"2007","unstructured":"Fang L et al (2007) Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci 80(23):2154\u20132160","journal-title":"Life Sci"},{"issue":"2","key":"4812_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/1074248410385683","volume":"16","author":"H Yu","year":"2011","unstructured":"Yu H et al (2011) Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy. J Cardiovasc Pharmacol Ther 16(2):205\u2013211","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"3","key":"4812_CR54","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/cvr\/cvs117","volume":"94","author":"J Piquereau","year":"2012","unstructured":"Piquereau J et al (2012) Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload. Cardiovasc Res 94(3):408\u2013417","journal-title":"Cardiovasc Res"},{"issue":"6265","key":"4812_CR55","doi-asserted-by":"publisher","first-page":"aad0116","DOI":"10.1126\/science.aad0116","volume":"350","author":"T Wai","year":"2015","unstructured":"Wai T et al (2015) Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science 350(6265):aad0116","journal-title":"Science"},{"key":"4812_CR56","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.yjmcc.2018.07.004","volume":"121","author":"P Hasan","year":"2018","unstructured":"Hasan P et al (2018) Mitochondrial fission protein, dynamin-related protein 1, contributes to the promotion of hypertensive cardiac hypertrophy and fibrosis in Dahl-salt sensitive rats. J Mol Cell Cardiol 121:103\u2013106","journal-title":"J Mol Cell Cardiol"},{"issue":"7201","key":"4812_CR57","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature07006","volume":"454","author":"H Sandoval","year":"2008","unstructured":"Sandoval H et al (2008) Essential role for Nix in autophagic maturation of erythroid cells. Nature 454(7201):232\u2013235","journal-title":"Nature"},{"issue":"1","key":"4812_CR58","doi-asserted-by":"publisher","first-page":"10501","DOI":"10.1038\/s41598-017-11251-8","volume":"7","author":"K Yang","year":"2017","unstructured":"Yang K et al (2017) Knockout of the ATPase inhibitory factor 1 protects the heart from pressure overload-induced cardiac hypertrophy. Sci Rep 7(1):10501","journal-title":"Sci Rep"},{"issue":"1","key":"4812_CR59","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/cells11010038","volume":"11","author":"V Choubey","year":"2021","unstructured":"Choubey V, Zeb A, Kaasik A (2021) Molecular mechanisms and regulation of mammalian mitophagy. Cells 11(1):38","journal-title":"Cells"},{"key":"4812_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.565751","volume":"11","author":"M Abudureyimu","year":"2020","unstructured":"Abudureyimu M et al (2020) Berberine promotes cardiac function by upregulating PINK1\/Parkin-mediated mitophagy in heart failure. Front Physiol 11:565751","journal-title":"Front Physiol"},{"issue":"3","key":"4812_CR61","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/CIRCRESAHA.115.304384","volume":"115","author":"M Song","year":"2014","unstructured":"Song M et al (2014) Super-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy. Circ Res 115(3):348\u2013353","journal-title":"Circ Res"},{"issue":"9","key":"4812_CR62","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1161\/CIRCRESAHA.118.314607","volume":"124","author":"M Tong","year":"2019","unstructured":"Tong M et al (2019) Mitophagy is essential for maintaining cardiac function during high fat diet-induced diabetic cardiomyopathy. Circ Res 124(9):1360\u20131371","journal-title":"Circ Res"},{"issue":"8","key":"4812_CR63","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/hrt.2005.068270","volume":"93","author":"M Seddon","year":"2007","unstructured":"Seddon M, Looi YH, Shah AM (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93(8):903\u2013907","journal-title":"Heart"},{"issue":"8","key":"4812_CR64","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1161\/01.CIR.98.8.794","volume":"98","author":"K Nakamura","year":"1998","unstructured":"Nakamura K et al (1998) Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98(8):794\u2013799","journal-title":"Circulation"},{"issue":"5","key":"4812_CR65","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/hh1701.096615","volume":"89","author":"DR Pimentel","year":"2001","unstructured":"Pimentel DR et al (2001) Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 89(5):453\u2013460","journal-title":"Circ Res"},{"issue":"1","key":"4812_CR66","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.cardiores.2004.08.013","volume":"65","author":"GX Zhang","year":"2005","unstructured":"Zhang GX et al (2005) Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res 65(1):230\u2013238","journal-title":"Cardiovasc Res"},{"issue":"10","key":"4812_CR67","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.freeradbiomed.2006.01.005","volume":"40","author":"HL Li","year":"2006","unstructured":"Li HL et al (2006) Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med 40(10):1756\u20131775","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"4812_CR68","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/CIRCRESAHA.108.186288","volume":"104","author":"J Guo","year":"2009","unstructured":"Guo J et al (2009) p66Shc links alpha1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphorylation pathway in cardiomyocytes. Circ Res 104(5):660\u2013669","journal-title":"Circ Res"},{"issue":"4","key":"4812_CR69","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.119.14400","volume":"75","author":"K Okabe","year":"2020","unstructured":"Okabe K et al (2020) DPP (Dipeptidyl Peptidase)-4 inhibitor attenuates Ang II (Angiotensin II)-induced cardiac hypertrophy via GLP (Glucagon-Like Peptide)-1-dependent suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 pathway. Hypertension 75(4):991\u20131001","journal-title":"Hypertension"},{"key":"4812_CR70","doi-asserted-by":"publisher","first-page":"7921363","DOI":"10.1155\/2017\/7921363","volume":"2017","author":"U Novoa","year":"2017","unstructured":"Novoa U et al (2017) High-intensity exercise reduces cardiac fibrosis and hypertrophy but does not restore the nitroso-redox imbalance in diabetic cardiomyopathy. Oxid Med Cell Longev 2017:7921363","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"4812_CR71","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.bbrc.2019.09.018","volume":"519","author":"T Ma","year":"2019","unstructured":"Ma T et al (2019) TRPC3 deficiency attenuates high salt-induced cardiac hypertrophy by alleviating cardiac mitochondrial dysfunction. Biochem Biophys Res Commun 519(4):674\u2013681","journal-title":"Biochem Biophys Res Commun"},{"key":"4812_CR72","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2018.03.054","volume":"266","author":"W Xiong","year":"2018","unstructured":"Xiong W et al (2018) PTEN induced putative kinase 1 (PINK1) alleviates angiotensin II-induced cardiac injury by ameliorating mitochondrial dysfunction. Int J Cardiol 266:198\u2013205","journal-title":"Int J Cardiol"},{"issue":"3","key":"4812_CR73","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.3390\/molecules17032738","volume":"17","author":"M Yu","year":"2012","unstructured":"Yu M et al (2012) Inhibitory effects of enalaprilat on rat cardiac fibroblast proliferation via ROS\/P38MAPK\/TGF-\u03b21 signaling pathway. Molecules 17(3):2738\u20132751","journal-title":"Molecules"},{"issue":"4","key":"4812_CR74","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/cells8040379","volume":"8","author":"C Yan","year":"2019","unstructured":"Yan C et al (2019) Mitochondrial DNA: distribution, mutations, and elimination. Cells 8(4):379","journal-title":"Cells"},{"issue":"3","key":"4812_CR75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/cvr\/cvn280","volume":"81","author":"H Tsutsui","year":"2009","unstructured":"Tsutsui H, Kinugawa S, Matsushima S (2009) Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 81(3):449\u2013456","journal-title":"Cardiovasc Res"},{"issue":"8","key":"4812_CR76","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4161\/auto.7.8.15813","volume":"7","author":"DF Dai","year":"2011","unstructured":"Dai DF, Rabinovitch P (2011) Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts. Autophagy 7(8):917\u2013918","journal-title":"Autophagy"},{"issue":"3","key":"4812_CR77","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/biomedicines9030258","volume":"9","author":"JM Su\u00e1rez-Rivero","year":"2021","unstructured":"Su\u00e1rez-Rivero JM et al (2021) From mitochondria to atherosclerosis: the inflammation path. Biomedicines 9(3):258","journal-title":"Biomedicines"},{"key":"4812_CR78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148852","author":"Y Huang","year":"2022","unstructured":"Huang Y et al (2022) Brown adipose TRX2 deficiency activates mtDNA-NLRP3 to impair thermogenesis and protect against diet-induced insulin resistance. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI148852","journal-title":"J Clin Invest"},{"issue":"3","key":"4812_CR79","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira K et al (2011) Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12(3):222\u2013230","journal-title":"Nat Immunol"},{"key":"4812_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102305","volume":"52","author":"Z Liu","year":"2022","unstructured":"Liu Z et al (2022) XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury. Redox Biol 52:102305","journal-title":"Redox Biol"},{"issue":"44","key":"4812_CR81","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1073\/pnas.1312571110","volume":"110","author":"T Ichinohe","year":"2013","unstructured":"Ichinohe T et al (2013) Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc Natl Acad Sci U S A 110(44):17963\u201317968","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4812_CR82","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.1038\/srep15489","volume":"5","author":"S Park","year":"2015","unstructured":"Park S et al (2015) Defective mitochondrial fission augments NLRP3 inflammasome activation. Sci Rep 5:15489","journal-title":"Sci Rep"},{"key":"4812_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111588","volume":"144","author":"S Mahalanobish","year":"2020","unstructured":"Mahalanobish S et al (2020) Melatonin induced suppression of ER stress and mitochondrial dysfunction inhibited NLRP3 inflammasome activation in COPD mice. Food Chem Toxicol 144:111588","journal-title":"Food Chem Toxicol"},{"key":"4812_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2021.02.002","volume":"84","author":"XL Zhang","year":"2021","unstructured":"Zhang XL et al (2021) Anti-inflammatory and neuroprotective effects of natural cordycepin in rotenone-induced PD models through inhibiting Drp1-mediated mitochondrial fission. Neurotoxicology 84:1\u201313","journal-title":"Neurotoxicology"},{"key":"4812_CR85","doi-asserted-by":"crossref","first-page":"6679100","DOI":"10.1155\/2021\/6679100","volume":"2021","author":"Y Chen","year":"2021","unstructured":"Chen Y et al (2021) Nlrp3 deficiency alleviates angiotensin II-induced cardiomyopathy by inhibiting mitochondrial dysfunction. Oxid Med Cell Longev 2021:6679100","journal-title":"Oxid Med Cell Longev"},{"key":"4812_CR86","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3389\/fimmu.2020.01647","volume":"11","author":"JV Alves","year":"2020","unstructured":"Alves JV et al (2020) Supraphysiological levels of testosterone induce vascular dysfunction via activation of the NLRP3 inflammasome. Front Immunol 11:1647","journal-title":"Front Immunol"},{"issue":"9","key":"4812_CR87","doi-asserted-by":"publisher","first-page":"Br266","DOI":"10.12659\/MSM.881930","volume":"17","author":"T Papamitsou","year":"2011","unstructured":"Papamitsou T et al (2011) Testosterone-induced hypertrophy, fibrosis and apoptosis of cardiac cells\u2013an ultrastructural and immunohistochemical study. Med Sci Monit 17(9):Br266\u2013Br273","journal-title":"Med Sci Monit"},{"key":"4812_CR88","doi-asserted-by":"publisher","first-page":"8316560","DOI":"10.1155\/2017\/8316560","volume":"2017","author":"H Guo","year":"2017","unstructured":"Guo H et al (2017) NLRP3 deficiency attenuates renal fibrosis and ameliorates mitochondrial dysfunction in a mouse unilateral ureteral obstruction model of chronic kidney disease. Mediators Inflamm 2017:8316560","journal-title":"Mediators Inflamm"},{"issue":"14","key":"4812_CR89","doi-asserted-by":"publisher","first-page":"17479","DOI":"10.18632\/oncotarget.8243","volume":"7","author":"W Ding","year":"2016","unstructured":"Ding W et al (2016) Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury. Oncotarget 7(14):17479\u201317491","journal-title":"Oncotarget"},{"key":"4812_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108046","volume":"99","author":"M Zhao","year":"2021","unstructured":"Zhao M et al (2021) Selective inhibition of NLRP3 inflammasome reverses pressure overload-induced pathological cardiac remodeling by attenuating hypertrophy, fibrosis, and inflammation. Int Immunopharmacol 99:108046","journal-title":"Int Immunopharmacol"},{"key":"4812_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.727474","volume":"9","author":"M Wang","year":"2022","unstructured":"Wang M et al (2022) MCC950, a selective NLRP3 inhibitor, attenuates adverse cardiac remodeling following heart failure through improving the cardiometabolic dysfunction in obese mice. Front Cardiovasc Med 9:727474","journal-title":"Front Cardiovasc Med"},{"key":"4812_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175364","volume":"937","author":"Y Shi","year":"2022","unstructured":"Shi Y et al (2022) The selective NLRP3 inflammasome inhibitor MCC950 improves isoproterenol-induced cardiac dysfunction by inhibiting cardiomyocyte senescence. Eur J Pharmacol 937:175364","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4812_CR93","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-021-00434-y","volume":"7","author":"R Yue","year":"2021","unstructured":"Yue R et al (2021) NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin. Cell Death Discov 7(1):50","journal-title":"Cell Death Discov"},{"issue":"1","key":"4812_CR94","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbrc.2017.02.021","volume":"485","author":"R Li","year":"2017","unstructured":"Li R et al (2017) Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression. Biochem Biophys Res Commun 485(1):69\u201375","journal-title":"Biochem Biophys Res Commun"},{"key":"4812_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107841","volume":"98","author":"B Ren","year":"2021","unstructured":"Ren B et al (2021) Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1\/NF-\u03baB pathway. Int Immunopharmacol 98:107841","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"4812_CR96","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/s41401-021-00703-7","volume":"42","author":"SL Lv","year":"2021","unstructured":"Lv SL et al (2021) Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation. Acta Pharmacol Sin 42(12):2016\u20132032","journal-title":"Acta Pharmacol Sin"},{"key":"4812_CR97","doi-asserted-by":"publisher","first-page":"112709","DOI":"10.1016\/j.biopha.2022.112709","volume":"148","author":"M Yan","year":"2022","unstructured":"Yan M et al (2022) The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation. Biomed Pharmacother 148:112709","journal-title":"Biomed Pharmacother"},{"key":"4812_CR98","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.freeradbiomed.2022.02.027","volume":"182","author":"F Wang","year":"2022","unstructured":"Wang F et al (2022) Silica nanoparticles induce pyroptosis and cardiac hypertrophy via ROS\/NLRP3\/Caspase-1 pathway. Free Radic Biol Med 182:171\u2013181","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"4812_CR99","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00394-021-02768-w","volume":"61","author":"XF Qu","year":"2022","unstructured":"Qu XF et al (2022) Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL\/6 mice and AC16 cells. Eur J Nutr 61(4):1823\u20131836","journal-title":"Eur J Nutr"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04812-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04812-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04812-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T07:47:46Z","timestamp":1729928866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04812-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["4812"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04812-1","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"3 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}